Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia, rigidity, and postural instability. [1 ] Parkinsonism shares symptoms found in [2 ] Parkinson's Disease, from which it is named; but parkinsonism is a symptom complex, and differs from Parkinson disease which is a progressive neurodegenerative illness. The underlying causes of parkinsonism are numerous, and diagnosis can be complex. [3 ] The [4 ] neurodegenerative condition Parkinson's disease (PD) is the most common cause of parkinsonism. However, a wide range of other etiologies may lead to a similar set of symptoms, including some toxins, a few metabolic diseases, and a handful of neurological conditions other than Parkinson's. [5 ]
About 7% of people with parkinsonism have developed their symptoms following treatment with particular medications. Side effect of medications, mainly neuroleptic antipsychotics especially the
phenothiazines (such as perphenazine and chlorpromazine), thioxanthenes (such as flupenthixol and zuclopenthixol) and butyrophenones (such as haloperidol (Haldol)), piperazines (such as ziprasidone), and, rarely, antidepressants. The incidence of drug-induced parkinsonism increases with age. Drug induced parkinsonism tends to remain at its presenting level, i.e. does not progress like the parkinson disease. [6 ]
Etiology [ edit ]
Progressive supranuclear palsy (PSP) [ edit ]
Corticobasal ganglionic degeneration (CBGD) [ edit ]
Multiple system atrophy (MSA) [ edit ]
Dementia with Lewy bodies (DLB) [ edit ]
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) [ edit ]
Parkinsonism-dementia complex of Guam (PDC) [ edit ]
Vascular parkinsonism [ edit ]
Toxin-induced parkinsonism [ edit ]
Differential diagnoses [ edit ]
Before Parkinson's disease is diagnosed the
differential diagnoses include:
AIDS can sometimes lead to the symptoms of secondary parkinsonism, due to commonly causing dopaminergic dysfunction. Indeed parkinsonism can be a presenting feature of HIV infection. [7 ]
Corticobasal degeneration [1 ]
Creutzfeldt-Jakob disease [8 ]
Dementia pugilistica or "boxer's dementia" is a condition that occurs in boxers due to chronic brain trauma
Diffuse Lewy body disease [1 ] Drug-induced parkinsonism ("pseudoparkinsonism") due to drugs such as
antipsychotics, metoclopramide, MPTP [1 ] [9 ]
Encephalitis lethargica [1 ]
Essential tremor, an illness which has some diagnostic overlap with Parkinson's disease. [10 ]
Multiple system atrophy [11 ]
Pantothenate kinase-associated neurodegeneration, also known as Neurodegeneration with brain iron accumulation (NBIA) or Hallervorden-Spatz syndrome [12 ] [13 ]
Parkinson plus syndrome
Progressive supranuclear palsy [1 ] Toxicity due to substances such as
carbon monoxide, [14 ] carbon disulfide, [14 ] manganese, [14 ] paraquat, [15 ] mercury, [16 ] hexane, rotenone, and toluene ( [17 ] inhalant abuse: "huffing") [18 ] Vascular parkinsonism
[19 ] [20 ]
Wilson's disease is a genetic disorder in which there is an abnormal accumulation of copper. The excess copper can lead to the formation of a copper- dopamine complex, which leads to the oxidation of dopamine to aminochrome. The most common manifestations include [21 ] bradykinesia, cogwheel rigidity and a lack of balance. [22 ] [23 ]
Paraneoplastic syndrome: neurological symptoms caused by antibodies associated with cancers Genetic
Rapid onset dystonia parkinsonism (DYT12)
X-linked dystonia parkinsonism (DYT3)
Autosomal recessive juvenile parkinsonism (ARJP)
References [ edit ]
^ a b c d e f Aminoff MJ, Greenberg DA, Simon RP (2005). Clinical Neurology (6th ed.). Lange: McGraw-Hill Medical. pp. 241–5. ISBN 0-07-142360-5.
^ Bradley J. Robottom; William J. Weiner; Lisa M. Shulman. "42". International Neurology: A Clinical Approach. Blackwell Publishing Ltd. pp. 152–158. ISBN 978-1-405-15738-4.
^ Rao G, Fisch L, Srinivasan S, et al. Does this patient have Parkinson disease? JAMA. 2003;289(3):347-353. PMID 12525236
^ Tuite PJ, Krawczewski K (2007). "Parkinsonism: a review-of-systems approach to diagnosis". Seminars in neurology 27 (2): 113–22. doi: 10.1055/s-2007-971174. PMID 17390256.
^ Christine CW, Aminoff MJ (2004). "Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance". Am. J. Med. 117 (6): 412–9. doi: 10.1016/j.amjmed.2004.03.032. PMID 15380498.
^ Tse W; Cersosimo MG; Gracies JM et al. (2004). "Movement disorders and AIDS: a review". Parkinsonism Relat. Disord. 10 (6): 323–34. doi: 10.1016/j.parkreldis.2004.03.001. PMID 15261874.
^ Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D (2006). "Movement disorders and Creutzfeldt-Jakob disease: a review". Parkinsonism Relat. Disord. 12 (2): 65–71. doi: 10.1016/j.parkreldis.2005.10.004. PMID 16364674.
^ Watanabe Y, Himeda T, Araki T (2005). "Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease" (PDF). Med. Sci. Monit. 11 (1): RA17–23. PMID 15614202.
^ Wenning GK, Geser F (2003). "Multiple system atrophy". Rev. Neurol. (Paris) 159 (5 Pt 2): 3S31–8. PMID 12773886.
^ Uc EY, Rodnitzky RL (2003). "Childhood dystonia". Seminars in pediatric neurology 10 (1): 52–61. doi: 10.1016/S1071-9091(02)00010-4. PMID 12785748.
^ Online 'Mendelian Inheritance in Man' (OMIM) NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1 -234200
^ a b c DeLong MR, Juncos JL (2004). Parkinson's Disease and Other Movement Disorders. In: Harrison's Principles of Internal Medicine (16th ed.). McGraw-Hill Professional. p. 2414. ISBN 0-07-140235-7.
^ Dinis-Oliveira RJ; Remião F; Carmo H et al. (2006). "Paraquat exposure as an etiological factor of Parkinson's disease". Neurotoxicology 27 (6): 1110–22. doi: 10.1016/j.neuro.2006.05.012. PMID 16815551.
^ Tremor/InvoluntaryMovements: Excerpt from Field Guide to Bedside Diagnosis
^ Weiss J. Chapter 151. Toluene and Xylene. In: Olson KR, ed. Poisoning & Drug Overdose. 6th ed. New York: McGraw-Hill; 2012. http://www.accessmedicine.com/content.aspx?aID=55982958. Accessed April 21, 2013.
^ Thanvi B, Lo N, Robinson T (2005). "Vascular Parkinsonism--an important cause of parkinsonism in older people" (PDF). Age and ageing 34 (2): 114–9. doi: 10.1093/ageing/afi025. PMID 15713855.
^ Członkowska A; Tarnacka B; Möller JC et al. (2007). "Unified Wilson's Disease Rating Scale — a proposal for the neurological scoring of Wilson's disease patients". Neurol. Neurochir. Pol. 41 (1): 1–12. PMID 17330175.
^ Ropper AH, Samuels MA. Chapter 4. Abnormalities of Movement and Posture Caused by Disease of the Basal Ganglia. In: Ropper AH, Samuels MA, eds. Adams and Victor's Principles of Neurology. 9th ed. New York: McGraw-Hill; 2009. http://www.accessmedicine.com/content.aspx?aID=3630437. Accessed April 21, 2013.
^ Lorincz MT (January 2010). "Neurologic Wilson's disease". Ann. N. Y. Acad. Sci. 1184: 173–87. doi: 10.1111/j.1749-6632.2009.05109.x. PMID 20146697.
External links [ edit ]